Company registration number 02061296 (England and Wales)
HEALTHCARE QUALITY QUEST LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
HEALTHCARE QUALITY QUEST LIMITED
COMPANY INFORMATION
Director
Mrs E Cox
Secretary
Mrs E Cox
Company number
02061296
Registered office
Units 10-11 Shelley Farm
Shelley Lane
Ower
Romsey
Hampshire
England
SO51 6AS
Accountants
Xeinadin South East Limited
12 Conqueror Court
Sittingbourne
Kent
United Kingdom
ME10 5BH
HEALTHCARE QUALITY QUEST LIMITED
CONTENTS
Page
Director's report
1
Accountants' report
2
Balance sheet
3
Notes to the financial statements
4 - 7
HEALTHCARE QUALITY QUEST LIMITED
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The director presents her annual report and financial statements for the year ended 31 December 2024.

Director

The director who held office during the year and up to the date of signature of the financial statements was as follows:

Mrs E Cox
STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent;

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the

company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

 

Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mrs E Cox
Director
25 September 2025
HEALTHCARE QUALITY QUEST LIMITED
REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY ACCOUNTS OF HEALTHCARE QUALITY QUEST LIMITED
- 2 -

These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the year ended 31 December 2024.

We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.

On the balance sheet, you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give a true and fair view.

You have determined that the company is exempt from the statutory requirement for an audit for this accounting year. Therefore, the financial statements are unaudited.

 

The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.

Xeinadin South East Limited
12 Conqueror Court
Sittingbourne
Kent
ME10 5BH
United Kingdom
25 September 2025
HEALTHCARE QUALITY QUEST LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 3 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
3
508
635
Tangible assets
4
14,678
18,318
15,186
18,953
Current assets
Stocks
9,474
6,379
Debtors
5
152,953
172,902
Cash at bank and in hand
418,640
465,184
581,067
644,465
Creditors: amounts falling due within one year
6
(140,684)
(145,385)
Net current assets
440,383
499,080
Net assets
455,569
518,033
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
454,569
517,033
Total equity
455,569
518,033

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 25 September 2025
Mrs E Cox
Director
Company registration number 02061296 (England and Wales)
HEALTHCARE QUALITY QUEST LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
1
Accounting policies
Company information

Healthcare Quality Quest Limited is a private company limited by shares incorporated in England and Wales. The registered office is Units 10-11 Shelley Farm, Shelley Lane, Ower, Romsey, Hampshire, England, SO51 6AS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
amortised evenly over its estimated useful life of five years
Patents & licences
amortised evenly over their estimated useful life of ten years
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

HEALTHCARE QUALITY QUEST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
15% on reducing balance
Computers
25% on reducing balance
1.5
Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

1.6
Financial instruments

The company enters into basic financial instruments, which result in the recognition of financial assets and liabilities. Financial instruments are recognised at amortised cost. At the end of each reporting period, financial instruments are assessed for evidence of impairment and changes are recognised in the Statement of Income and Retained Earnings.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

HEALTHCARE QUALITY QUEST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
4
4
3
Intangible fixed assets
Other
£
Cost
At 1 January 2024 and 31 December 2024
6,345
Amortisation and impairment
At 1 January 2024
5,710
Amortisation charged for the year
127
At 31 December 2024
5,837
Carrying amount
At 31 December 2024
508
At 31 December 2023
635
4
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 January 2024
51,632
93,596
145,228
Business combinations
-
0
851
851
At 31 December 2024
51,632
94,447
146,079
Depreciation and impairment
At 1 January 2024
48,629
78,281
126,910
Depreciation charged in the year
450
4,041
4,491
At 31 December 2024
49,079
82,322
131,401
Carrying amount
At 31 December 2024
2,553
12,125
14,678
At 31 December 2023
3,003
15,315
18,318
HEALTHCARE QUALITY QUEST LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
110,019
135,065
Other debtors
42,934
37,837
152,953
172,902
6
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
-
0
254
Trade creditors
178
2,940
Taxation and social security
20,599
22,205
Other creditors
119,907
119,986
140,684
145,385
2024-12-312024-01-01falsefalsefalse25 September 2025CCH SoftwareCCH Accounts Production 2025.200No description of principal activityMrs E CoxMrs E Cox020612962024-01-012024-12-3102061296bus:CompanySecretaryDirector12024-01-012024-12-3102061296bus:CompanySecretary12024-01-012024-12-3102061296bus:Director12024-01-012024-12-3102061296bus:RegisteredOffice2024-01-012024-12-31020612962024-12-31020612962023-12-3102061296core:IntangibleAssetsOtherThanGoodwill2024-12-3102061296core:IntangibleAssetsOtherThanGoodwill2023-12-3102061296core:FurnitureFittings2024-12-3102061296core:ComputerEquipment2024-12-3102061296core:FurnitureFittings2023-12-3102061296core:ComputerEquipment2023-12-3102061296core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3102061296core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3102061296core:ShareCapital2024-12-3102061296core:ShareCapital2023-12-3102061296core:RetainedEarningsAccumulatedLosses2024-12-3102061296core:RetainedEarningsAccumulatedLosses2023-12-3102061296core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3102061296core:ComputerSoftware2024-01-012024-12-3102061296core:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3102061296core:FurnitureFittings2024-01-012024-12-3102061296core:ComputerEquipment2024-01-012024-12-31020612962023-01-012023-12-3102061296core:IntangibleAssetsOtherThanGoodwill2023-12-3102061296core:FurnitureFittings2023-12-3102061296core:ComputerEquipment2023-12-31020612962023-12-3102061296core:CurrentFinancialInstruments2024-12-3102061296core:CurrentFinancialInstruments2023-12-3102061296core:WithinOneYear2024-12-3102061296core:WithinOneYear2023-12-3102061296bus:PrivateLimitedCompanyLtd2024-01-012024-12-3102061296bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3102061296bus:FRS1022024-01-012024-12-3102061296bus:AuditExemptWithAccountantsReport2024-01-012024-12-3102061296bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP